Thiol antioxidants regulate angiotensin II AT1 and arginine vasopressin V1 receptor functions differently in vascular smooth muscle cells.
暂无分享,去创建一个
[1] T. Morinelli,et al. N-acetylcysteine decreases angiotensin II receptor binding in vascular smooth muscle cells. , 2005, Journal of the American Society of Nephrology : JASN.
[2] H. Abboud,et al. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. , 2004, The Biochemical journal.
[3] Maristela L Onozato,et al. Angiotensin II and Oxidative Stress in Dahl Salt-Sensitive Rat With Heart Failure , 2002, Hypertension.
[4] W. Welch,et al. A mouse model of angiotensin II slow pressor response: role of oxidative stress. , 2002, Journal of the American Society of Nephrology : JASN.
[5] P. Tangkijvanich,et al. Vasopressin-mediated mitogenic signaling in intestinal epithelial cells. , 2002, American journal of physiology. Cell physiology.
[6] L. Juncos,et al. Antioxidants Block Angiotensin II-Induced Increases in Blood Pressure and Endothelin , 2001, Hypertension.
[7] S. Fluharty,et al. Identification and function of disulfide bridges in the extracellular domains of the angiotensin II type 2 receptor. , 2001, Biochemistry.
[8] J. Kreisberg,et al. Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor. , 2001, American journal of physiology. Renal physiology.
[9] N. Cotte,et al. Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding. , 2000, European journal of biochemistry.
[10] T. Taniguchi,et al. Participation of Reactive Oxygen Intermediates in the Angiotensin II‐Activated Signaling Pathways in Vascular Smooth Muscle Cells , 2000, Annals of the New York Academy of Sciences.
[11] T. Peng,et al. Angiotensin II activation of insulin-like growth factor 1 receptor transcription is mediated by a tyrosine kinase-dependent redox-sensitive mechanism. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[12] W R Taylor,et al. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. , 1998, Hypertension.
[13] E. Jaimes,et al. Angiotensin II induces superoxide anion production by mesangial cells. , 1998, Kidney international.
[14] M. Shibuya,et al. Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor. , 1998, Circulation research.
[15] G. H. Thoresen,et al. Activation of p42/p44 mitogen‐activated protein kinase by angiotensin II, vasopressin, norepinephrine, and prostaglandin F2α in hepatocytes is sustained, and like the effect of epidermal growth factor, mediated through pertussis toxin‐sensitive mechanisms , 1998, Journal of cellular physiology.
[16] H. Kawakatsu,et al. Calcium-dependent Epidermal Growth Factor Receptor Transactivation Mediates the Angiotensin II-induced Mitogen-activated Protein Kinase Activation in Vascular Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.
[17] J. Leor,et al. Stimulation of 42/44 kDa mitogen-activated protein kinases by arginine vasopressin in rat cardiomyocytes. , 1998, Biochimica et biophysica acta.
[18] I. Siemens,et al. Cloning and expression of angiotensin II type 2 (AT2) receptors from murine neuroblastoma N1E-115 cells: evidence for AT2 receptor heterogeneity. , 1997, Brain research. Molecular brain research.
[19] B. Berk,et al. Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells, Role of Raf. , 1996, Circulation research.
[20] D. Harrison,et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.
[21] T. Inagami,et al. Disulfide bridges in extracellular domains of angiotensin II receptor type IA , 1995, Regulatory Peptides.
[22] W. Greenlee,et al. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. , 1994, The Journal of biological chemistry.
[23] R W Alexander,et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. , 1994, Circulation research.
[24] D. Rabenstein,et al. Characterization of the thiol/disulfide chemistry of neurohypophyseal peptide hormones by high-performance liquid chromatography. , 1993, Analytical chemistry.
[25] S. Chaki,et al. Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis. , 1992, Biochemical and biophysical research communications.
[26] J. Duncia,et al. Discrimination of angiotensin II receptor subtypes by dithiothreitol. , 1989, European journal of pharmacology.
[27] D. Butkus,et al. Modulation of vasopressin action by reducing agents in Bufo marinus. , 1982, The American journal of physiology.
[28] M. Greer,et al. Differential effects of dithiothreitol and iodoacetamide on corticotropin-releasing factor (CRF) activity of bovine hypothalamic CRFs and vasopressin. , 1982, Endocrinology.
[29] T. Meinertz,et al. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. , 1999, Kidney international.